Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s15010-020-01553-x http://scihub22266oqcxt.onion/10.1007/s15010-020-01553-x 33393065!7779094!33393065     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infection 2021 ; 49 (3): 559-562 Nephropedia Template TP {{tp|p=33393065|t=2021. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia |pdf=|usr=}}{{33393065}} gab.com Text Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia JO: Infection http://www.kidney.de/pget.php?&tw=1&pmid=33393065 #FOAvip Severe 2019 novel coronavirus infectious disease (COVID-19) with pneumonia is associated with high rates of admission to the intensive care unit (ICU). Bacterial coinfection has been reported to be rare. We aimed at describing the rate of bacterial coinfection in critically ill adult patients with severe COVID-19 pneumonia. All the patients with laboratory-confirmed severe COVID-19 pneumonia admitted to the ICU of Tenon University-teaching hospital, from February 22 to May 7th, 2020 were included. Respiratory tract specimens were obtained within the first 48 h of ICU admission. During the study period, 101 patients were referred to the ICU for COVID-19 with severe pneumonia. Most patients (n = 83; 82.2%) were intubated and mechanically ventilated on ICU admission. Overall, 20 (19.8%) respiratory tract specimens obtained within the first 48 h. Staphylococcus aureus was the main pathogen identified, accounting for almost half of the early-onset bacterial etiologies. We found a high prevalence of early-onset bacterial coinfection during severe COVID-19 pneumonia, with a high proportion of S. aureus. Our data support the current WHO guidelines for the management of severe COVID-19 patients, in whom antibiotic therapy directed to respiratory pathogens is recommended. Twit Text FOAVip Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia ????Infection http://www.kidney.de/pget.php?&tw=1&pmid=33393065 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33393065 #FOAvip English Wikipedia <ref>{{Cite pmid|33393065}}</ref> Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia #MMPMID33393065 Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M Infection 2021[Jun]; 49 (3): 559-562 PMID33393065show ga Severe 2019 novel coronavirus infectious disease (COVID-19) with pneumonia is associated with high rates of admission to the intensive care unit (ICU). Bacterial coinfection has been reported to be rare. We aimed at describing the rate of bacterial coinfection in critically ill adult patients with severe COVID-19 pneumonia. All the patients with laboratory-confirmed severe COVID-19 pneumonia admitted to the ICU of Tenon University-teaching hospital, from February 22 to May 7th, 2020 were included. Respiratory tract specimens were obtained within the first 48 h of ICU admission. During the study period, 101 patients were referred to the ICU for COVID-19 with severe pneumonia. Most patients (n = 83; 82.2%) were intubated and mechanically ventilated on ICU admission. Overall, 20 (19.8%) respiratory tract specimens obtained within the first 48 h. Staphylococcus aureus was the main pathogen identified, accounting for almost half of the early-onset bacterial etiologies. We found a high prevalence of early-onset bacterial coinfection during severe COVID-19 pneumonia, with a high proportion of S. aureus. Our data support the current WHO guidelines for the management of severe COVID-19 patients, in whom antibiotic therapy directed to respiratory pathogens is recommended. |Aged[MESH] |Anti-Bacterial Agents/therapeutic use[MESH] |Bacteria/classification/isolation & purification[MESH] |Bacterial Infections/diagnosis/drug therapy/*epidemiology[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/diagnosis/*epidemiology[MESH] |Coinfection/diagnosis/drug therapy/*epidemiology[MESH] |Critical Illness[MESH] |Female[MESH] |Hospitals, University[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Male[MESH] |Middle Aged[MESH] |Prevalence[MESH] |SARS-CoV-2/isolation & purification[MESH]Bacterial coinfection in critically ill COVID-19 patients with severe (epmc).pdf DeepDyve Pubget Overpricing